PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision.

• BOXABL recently began trading on the Nasdaq, marking the latest stage in the company’s ongoing expansion of its factory-built housing platform.
• The company is applying advanced manufacturing, automation and AI to standardize home production and improve construction efficiency.
• BOXABL is directly addressing major issues of the large but troubled U.S. housing market, including persistent affordability challenges and an estimated multi-million-unit housing shortage.
• The company’s modular platform is designed to support single-family homes, multifamily developments, hotels, and mixed-use projects.
• While the small and highly affordable Casita is its initial product, the company is already developing larger housing units and modular configurations for broader residential and commercial applications.
• BOXABL’s business model plans to combine home production with complementary services including financing, insurance, and maintenance.

BOXABL (NASDAQ: BXBL), an innovative technology construction company addressing the U.S. and ultimately global housing crisis, has entered a new phase of its corporate development following its recent listing on the Nasdaq, providing public market investors with exposure to a company seeking to modernize residential construction through factory-built modular housing.

The Nasdaq listing comes as housing affordability and supply remain among the most significant long-term challenges facing the U.S. residential market. BOXABL is positioning its manufacturing platform around those foundational issues by moving much of the homebuilding process from construction sites into a controlled factory environment in ways intended to improve efficiency relative to traditional construction methods (https://ibn.fm/RHyqf).

BOXABL has developed a standardized construction system intended to improve production efficiency, cost predictability, and scalability. The company’s approach combines specialized engineering, manufacturing, and modular design, into a repeatable production process to cover a broad range of housing needs.

At the center of the platform is BOXABL’s folding building technology. Homes are manufactured in a compact configuration that can be transported using standard trailers before unfolding on-site into completed residential structures. The design is intended to simplify transportation logistics while allowing factory production to replace many of the labor-intensive steps associated with conventional construction.

The company’s initial and best-known product is the Casita, a fully finished modular home measuring approximately 361 square feet. Each unit includes a kitchen, bathroom and living space and is designed for rapid installation after delivery. BOXABL also plans to offer the Baby Box, a smaller RV-code unit intended for applications that require greater deployment flexibility. A potential start date for production of Baby Box has not yet been finalized.

However, management emphasizes that the company’s long-term strategy extends well beyond compact homes. The same modular construction platform is designed to support larger residences, with one-bedroom and two-bedroom layouts already available and additional larger base units under development. Individual modules can also be connected or stacked to create significantly larger structures.

That flexibility expands the potential range of applications beyond entry-level housing. BOXABL envisions its system supporting single-family homes, townhouses, multifamily residential developments, hotels, workforce housing and mixed-use commercial projects. By using standardized components across multiple building types, the company aims to create manufacturing efficiencies that are difficult to achieve through traditional site-built construction.

Production takes place at the company’s approximately 400,000-square-foot manufacturing facility in Las Vegas. BOXABL continues refining manufacturing processes and expanding production capabilities. Automation plays an increasingly important role within that strategy. The company is integrating robotics, artificial intelligence, and digital manufacturing tools into factory operations to optimize production efficiency and reduce defects. 

The market opportunity remains substantial. Company estimates place the total addressable U.S. housing market at approximately $2.2 trillion, based on an estimated need for more than 5 million additional homes. Persistent affordability challenges and years of underbuilding have contributed to a structural housing shortage that continues to plague many regions of the country.

Within that broader market, BOXABL initially targets the modular and manufactured housing segment, estimated to represent roughly $36 billion in annual opportunity. Management estimates that a factory, outfitted with up-to-date automated manufacturing processes and equipment operating at full capacity could produce approximately 5,000 homes annually, creating an initial serviceable obtainable market approaching $1 billion.

The company also believes its business model extends beyond manufacturing homes. In addition to home sales, BOXABL plans to generate recurring and higher-margin revenue through complementary services including financing, insurance, maintenance and related homeowner offerings. Management views those services as an important component of long-term customer relationships and overall business economics. These service lines are stated goals and not yet a meaningful part of reported revenue.

For more information, visit the company’s website at www.Boxabl.com.

NOTE TO INVESTORS: The latest news and updates relating to BXBL are available in the company’s newsroom at https://ibn.fm/BXBL

Cautionary Note Regarding the Business Combination and Capital Structure. BOXABL Inc. became a publicly traded company through a business combination with FG Merger II Corp., a special purpose acquisition company, completed in July 2026, with the shares beginning trading on the Nasdaq Stock Market under the symbol BXBL on July 20, 2026. Companies that become public through special purpose acquisition transactions may be subject to risks including share price volatility, dilution, limited operating history as a public company, and redemption-related capital reductions. In July 2026, the Company filed a universal mixed shelf registration statement that would permit it to offer up to $500,000,000 of securities over time; any such issuance would be dilutive to existing holders. References to capital raised since inception and to the number of investors are as disclosed by the Company. Readers should review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov, including its periodic reports, in full.

Cautionary Note Regarding Forward-Looking Statements. This publication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including projections of market opportunity and market share, estimates of customer adoption, projections of development and commercialization costs and timelines, expectations regarding the Company’s ability to execute its business model, the deployment of the Casita, the development and potential production of the Baby Box and of stackable and connectable modules, the pursuit of additional state regulatory approvals, expectations concerning relationships with customers, developers, strategic partners, suppliers, governments and regulatory bodies, and the potential for future projects. Such statements are generally identified by words such as “plan”, “project”, “will”, “estimate”, “intend”, “expect”, “believe”, “target”, “continue”, “could”, “may”, “might”, “possible”, “potential” or “predict”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause actual circumstances, events, or results to differ materially, including manufacturing, supply chain, permitting, regulatory, financing, dilution, listing, competitive and market risks, and other risks identified in the Company’s filings with the Securities and Exchange Commission. Do not place undue reliance on such statements. The forward-looking statements in this publication are made as of the date above and IBN undertakes no obligation to update them.

Full Disclaimer. NetworkNewsWire (“NNW”) is a division of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company. IBN has been compensated for advertising and digital media services for BOXABL Inc. This publication is for informational purposes only and is not, and should not be construed as, a research report, investment advice, or a recommendation to buy or sell any security. The information contained herein is believed to be reliable but no guarantee can be made as to its accuracy or completeness. Neither IBN nor NNW is registered as an investment adviser or broker-dealer. Readers should review BOXABL Inc.’s filings with the U.S. Securities and Exchange Commission and consult with a licensed financial advisor before making any investment decision. Please see the full terms of use and disclaimers applicable to all content provided by IBN, wherever published or re-published, at https://IBN.fm/Disclaimer.

• The company reported continued growth of its SSi Mantra surgical robotic system, with installations reaching 238 as of September 8, 2026, with the installed base now spanning 12 countries, following recent launches in Colombia and Sri Lanka and further international expansion.
• The company said cumulative SSi Mantra procedures reached 14,103, a 79% increase from 7,885 at the end of 2025.
• Pediatric applications continue to expand, including a robotic kidney procedure performed on a 45-day-old infant in India using 5-millimeter instruments.
• SS Innovations reported 188 cumulative robotic telesurgeries as of August 31, alongside long-distance procedures connecting surgeons and patients across countries.
• The company expects FDA review of its 510(k) submission by the end of Q1 2027 and believes EU CE marking for SSi Mantra could be obtained by the end of 2026.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is reporting continued growth in the use of its SSi Mantra surgical robotic system, with the company’s installed base and procedure count increasing as it expands into new countries and surgical applications.

In an update issued September 10, the company said 238 SSi Mantra systems were installed as of September 8, up 42% from 168 at the end of 2025. Procedures performed with the system reached 14,103, representing a 79% increase from 7,885 at year-end. The company also said approximately 1,500 physicians have now been trained on SSi Mantra, which has been used in more than 170 different types of surgical procedures (https://ibn.fm/PESjb).

International expansion remains a central component of that growth. On July 29, SS Innovations said Dr. Sudhir Srivastava, its chairman and CEO, launched a robotic cardiac surgery program at La Fundación Cardiovascular de Colombia in Bucaramanga. The program included Colombia’s first Totally Endoscopic Beating-Heart Bypass Surgery performed using SSi Mantra.

Less than a month later, Kings Hospital Colombo installed the first SSi Mantra system in Sri Lanka. The company said the system subsequently supported the country’s first robotic-assisted cardiac surgery and more than 25 additional robotic procedures during its first three weeks of operation.

The Sri Lankan launch followed the company’s earlier expansion into other international markets and brought the global installed base to 12 countries. These deployments are significant for SS Innovations because regulatory approvals and clinical adoption outside its established Indian market are important steps in building a broader commercial footprint. The company is simultaneously pursuing U.S. Food and Drug Administration clearance and European regulatory certification.

SS Innovations expects the FDA to complete its review of the SSi Mantra 510(k) premarket notification by the end of the first quarter of 2027. The company believes it can obtain European Union CE marking by the end of 2026.

The latest update also highlighted the system’s use in pediatric surgery, where smaller anatomy places particular demands on surgical instruments and robotic control. On August 14, Dr. M. Ramalingam used SSi Mantra with 5-millimeter instrumentation to perform a robotic pyeloplasty on a 45-day-old infant at Hindusthan Hospital in Coimbatore, India. SS Innovations said the procedure was completed successfully and that the infant recovered rapidly. As of August 31, the company reported 258 pediatric robotic surgeries performed with SSi Mantra.

Telesurgery is another area where SS Innovations has accumulated a growing body of experience, although it remains an emerging application rather than the company’s primary commercial revenue driver. On July 29, a team led by Dr. Srivastava performed a robotic sleeve gastrectomy remotely between Colombia and India. The company said the procedure involved more than 13,600 miles, or approximately 22,000 kilometers, of fiber-network distance. The remote procedure connected Hospital Internacional de Colombia in Bucaramanga with Mohak Bariatrics and Robotics in Indore, India.

SS Innovations subsequently reported another telesurgery milestone in India. On August 9, surgeons at the company’s headquarters in Gurugram remotely performed three procedures on patients at Shalby Hospital in Ahmedabad, covering approximately 950 kilometers.

On September 5, SSi Mantra was used for what the company described as the first telesurgery within the Philippines, connecting Pampanga and Cotabato across approximately 1,710 kilometers.

As of August 31, the company said 188 robotic telesurgeries had been completed using SSi Mantra. The technology is also being tested at higher utilization levels. On August 15, a surgical team at Mohak Bariatrics and Robotics used five SSi Mantra systems to complete 50 robotic general-surgery procedures in one day.

SS Innovations has been building its installed base primarily around India, where it has had several years to train surgeons and expand procedure volumes. The company is now seeking to replicate that model internationally. 

“Our advanced, cost-effective SSi Mantra surgical robotic system is benefitting lives globally, one patient at a time, from a 45-day old baby needing kidney surgery in India to a cardiac patient in Sri Lanka,” said Dr. Srivastava. “Our progress in democratizing access to state-of-the-art surgical robotic care continues to be reflected in growing SSi Mantra installations, procedures and utilization.”

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• Forward Industries has released an open letter to shareholders of SkyAI, urging them to vote against SkyAI’s 2026 Equity Incentive Plan at SkyAI’s annual meeting.
• This follows the Board of SkyAI rejecting a proposal from Forward to acquire the company, which would have been an opportunity for shareholders to realize a 20% premium.
• In addition to highlighting this rejected opportunity for shareholders, the letter also mentions SkyAI’s mounting losses and underperformance relative to its peers.

Forward Industries (NASDAQ: FWDI), a Solana (SOL) treasury company, just released an open letter to shareholders of SkyAI outlining its concerns and announcing that it urges shareholders to vote against SkyAI’s 2026 Equity Incentive Plan and withhold on each of SkyAI’s five director nominees at SkyAI’s annual meeting of shareholders that’s scheduled for Sept. 18 (https://ibn.fm/DJora).

In the letter, Forward said it believes in the value opportunity at SkyAI and that a combination between the two could unlock value for the shareholders of both companies. It also outlined the proposal it submitted to acquire SkyAI in an all-stock transaction, which was a proposal that valued SkyAI at $1.55 per share, which was a 20% premium on its closing price prior to the proposal.

Ultimately, instead of engaging with Forward about the potential combination, the Board at SkyAI unanimously rejected the proposal. In addition to disagreeing with the decision then, Forward stated that SkyAI’s subsequent disclosures have only increased its concerns about the Board’s judgment.

Forward, which has assembled the largest Solana treasury, built a platform designed to compound SOL per share, and supports the continued growth of the SOL ecosystem, initially approached SkyAI because it believed that the combined scale, resources, and capabilities of the companies could create a stronger platform within the SOL ecosystem. It also believed that the move would unlock greater value for Forward and SkyAI shareholders.

At the upcoming annual meeting, SkyAI is asking shareholders to approve a new equity incentive plan that would dilute their ownership to provide additional equity compensation to the Board and management team that have failed to deliver commensurate value to shareholders in Forward’s view. SkyAI is also asking them to re-elect the same five directors who have overseen it during a period of significant value destruction.

Forward urges shareholders to vote “AGAINST” SkyAI’s 2026 Equity Incentive Plan, and vote “WITHHOLD” on each of SkyAI’s five director nominees.

It outlined the reasons for the request in the letter, which include the Board rejecting an opportunity for shareholders to realize a 20% premium, related-party payments that exceeded SkyAI’s entire market value, and SkyAI’s mounting losses and underperformance compared to peers.

Near the end of the letter, Forward asks SkyAI shareholders to participate in the meeting to have the opportunity to hold the Board accountable and make their opposition count.

This communication is being provided as an exempt solicitation pursuant to Rule 14a-2(b)(1) under the Securities Exchange Act of 1934, and Forward isn’t seeking authority to act as proxy for any SkyAI shareholder.

The information contained in the letter reflects Forward’s views as of the date hereof and is based on publicly available information, including disclosures made by SkyAI, that Forward believes to be reliable. Forward has not independently verified such information and does not represent that it is complete or accurate. 

About Forward Industries Inc. (NASDAQ: FWDI)

Forward Industries is building and managing a large-scale Solana (SOL) treasury and is backed by many of the most influential investors in the digital space. It aims to create long-term value through actively participating in the Solana ecosystem by deploying assets through on-chain opportunities like staking, lending, and participating in decentralized finance (“DeFi”). Forward is also the first U.S.-listed company to bring its stock onto the Solana blockchain.

For more information, visit the Forward Industries website at www.ForwardIndustries.com.

NOTE TO INVESTORS: The latest news and updates relating to FWDI are available in the company’s newsroom at https://ibn.fm/FWDI

• Energy is one of the sectors where the debt vs. equity decision has become especially pressing.
• As Market Street frames it, the tradeoff is straightforward in concept but consequential in practice.
• This is the kind of decision Market Street Capital’s platform is built to help energy founders work through.

For a growing number of middle-market energy founders, the hardest strategic decision is not what to build next but how to pay for it. Market Street Capital, a capital markets and financial advisory firm, works with established middle-market businesses navigating exactly this kind of decision. The company’s team members have spent more than two decades helping owners weigh whether debt, equity or some combination of the two best fits their growth plans.

Energy is one of the sectors where that decision has become especially pressing. Power demand tied to artificial intelligence, electrification and data center buildout is reshaping capital needs across the industry. According to PwC’s midyear 2026 outlook on U.S. energy deals, rising power demand and infrastructure access are now central to how energy assets are valued, with hyperscalers and industrial users driving investment across natural gas, liquified natural gas (“LNG”) and dedicated generation. In addition, deal value rose 80.5% year to date compared to the first half of 2025, a shift attributed to power becoming the binding constraint on new infrastructure development rather than capital itself.

For founders running established, cash-generating energy businesses, that demand creates real growth opportunity, but funding it raises the same fundamental question every growing company faces: debt or equity. As Market Street frames it, the tradeoff is straightforward in concept but consequential in practice. Debt generally preserves ownership and avoids dilution, but it creates fixed repayment obligations regardless of performance, along with covenants and collateral requirements that can constrain flexibility. Equity generally carries no scheduled repayment obligation and is intended to align investor returns with company performance. However, it also reduces a founder’s share of future profits and often introduces new governance dynamics, including board representation and investor input on major decisions.

The economics of that choice matter too. The after-tax cost of debt financing typically runs between 3 and 8%, while equity investors generally expect returns in the range of 15 to 25%, which may make debt less expensive than equity for companies with the cash flow to support it, depending on the borrower and market conditions. 

That said, access to debt is not always straightforward. Post-2008 regulatory changes pushed banks toward tighter lending standards, particularly for companies without investment-grade credit or substantial hard assets, a gap that has fueled rapid growth in private credit. Morgan Stanley estimates that the private credit market stood at roughly $2 trillion in 2020, grew to about $3 trillion entering 2025 and is projected to reach approximately $5 trillion by 2029, much of it aimed at middle-market borrowers that cannot access broadly syndicated loan markets.

That growth has expanded the toolkit available to energy founders well beyond a simple bank loan. Senior debt, unitranche facilities, mezzanine financing and asset-based lending each offer different pricing, covenant structures and risk profiles, and the right fit depends on the specific project or growth initiative being financed. Mezzanine debt sits between senior debt and equity, filling the gap between what a senior lender will provide and what a founder wants to contribute in equity. Unitranche facilities combine senior and subordinated debt into a single loan agreement with one blended rate, often simplifying and accelerating deal execution compared with a traditional multitranche structure.

Equity still has its place, particularly for founders pursuing genuinely transformational moves, entering a new market, funding a major platform acquisition or building out generation capacity that may not produce returns for several years. In those cases, patient equity capital from aligned investors can offer more flexibility than debt, which requires scheduled payments regardless of how quickly a new asset ramps up.

This is the kind of decision Market Street Capital’s platform is built to help energy founders work through. The firm’s debt capital markets and specialty lending practice seeks to connect clients with senior debt, unitranche and mezzanine structures, and asset-based lending through relationships with banks, private credit funds, insurance companies and specialty finance providers. For founders who determine equity is the better path, Market Street’s private equity raises practice works with clients to structure and execute customized raises and to introduce them to institutional investors, family offices and private equity sponsors. Any securities-related activity, including the placement of securities, is conducted through Pickwick Capital Partners, LLC, Member FINRA/SIPC. No financing or transaction outcome can be assured.

As power demand continues to reshape the energy sector’s capital needs, the founders best positioned to capture that growth may be those that treat the financing decision with the same rigor as the underlying business plan. That means matching each dollar raised to the cash flow profile and time horizon it is meant to support, rather than defaulting to whichever source of capital is easiest to access in the moment.

For more information about the company, visit www.MarketStreetCP.com.

NOTE TO INVESTORS: The latest news and updates relating to Market Street are available in the company’s newsroom at https://ibn.fm/MarketSt

Disclosures:

This article is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any such offer may be made only pursuant to definitive offering materials and applicable transaction documents.

Nothing in this article is tax, legal or accounting advice. Readers should consult their own advisers.

Market data and third-party information are from sources believed to be reliable but have not been independently verified. No representation is made as to accuracy or completeness. Statements about financing structures and transaction outcomes are general in nature; no financing or transaction outcome can be assured. Any investment in securities is illiquid and speculative and is subject to a risk of loss, including a risk of the total loss of principal. Market Street Capital and its associated persons may have conflicts of interest, including transaction-based compensation, in connection with the services described.

Broker-dealer services are provided by Pickwick Capital Partners, LLC, Member FINRA/SIPC.

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision.

• BOXABL has begun trading on Nasdaq under the ticker symbol BXBL.
• The move values BOXABL at approximately $3.5 billion, with approximately 350 million shares issued at $10 per share.
• The company has so far raised over $230 million from 50,000+ investors.
• BOXABL is pursuing a technology-driven approach to factory-built housing, emphasizing automation, standardized production, and scalable manufacturing.
• The company has produced more than 800 modular homes while expanding manufacturing capacity at its Las Vegas production facility.
• Management is expanding beyond its flagship Casita product with additional housing formats targeting residential, multifamily, and commercial applications.

BOXABL (NASDAQ: BXBL), an innovative technology construction company on a mission to solve the global housing crisis, is now trading on Nasdaq under the symbol BXBL. To date, BOXABL has raised over $230 million from more than 50,000 investors, indicating substantial public interest in its vision. 

The transaction represents a significant milestone for the company as it seeks to expand production of its factory-built housing platform while addressing growing demand for more affordable residential construction.

The Nasdaq listing represents the next stage in BOXABL’s evolution from a privately funded startup into a growing publicly traded manufacturing company, placing greater emphasis on the company’s ability to execute its production strategy at scale while operating under the financial transparency and performance expectations associated with public markets.

BOXABL aims to disrupt the traditional housing construction industry by delivering affordable, high-quality homes at an accelerated pace. The company has attracted attention through its approach to factory-built housing, which differs from traditional site-built residential construction. Rather than assembling homes at individual building sites, the company manufactures standardized housing units inside its Las Vegas production facility before transporting them in a folded configuration for installation at their final location.

Its flagship product, the Casita, is a 361-square-foot studio-style home equipped with a kitchen, bathroom and living area, designed to unfold on-site in under an hour. The unit is engineered to fold to highway-legal dimensions, allowing transportation without many of the specialized permits typically required for modular housing.

BOXABL is also broadening its product portfolio building upon its original Casita design. The company recently introduced the Baby Box, a smaller, 120-square-foot unit built to recreational vehicle standards that offers greater deployment flexibility in certain jurisdictions. Larger modular units remain under development and are intended to support townhomes, multifamily housing, hotels and mixed-use developments through stackable and connectable building designs.

Management believes factory production can reduce several inefficiencies associated with conventional construction, including weather delays, fragmented subcontractor coordination and inconsistent building schedules.

Unlike many traditional manufactured housing companies, BOXABL emphasizes automation and standardized manufacturing techniques similar to those used in advanced industrial production. The company’s manufacturing campus now encompasses approximately 400,000 square feet, serving as the primary proving ground for its automated production system.

According to BOXABL, the company has completed installations across multiple states, including Nevada, California, Utah, Oklahoma, South Carolina, Arizona and Texas. Management also reports that production efficiencies have contributed to a 43% reduction in manufacturing costs since 2022, supported by assembly-line improvements, automation initiatives and larger purchasing volumes.

Management believes additional automation and artificial intelligence can play an important role in improving factory efficiency, amid growing demand for affordable housing. The company has been incorporating AI and digital manufacturing technologies into production operations to optimize throughput, reduce defects and improve quality control, reflecting broader trends across advanced manufacturing sectors.

Management estimates the company’s total addressable market at approximately $2.2 trillion, citing persistent housing shortages, annual residential demand and continuing affordability pressures that have resulted in an approximately shortfall of 5 million homes throughout the United States. Industry studies continue to estimate that millions of additional housing units are needed nationally, while elevated construction costs have complicated efforts to increase supply using conventional building methods. BOXABL believes factory-built modular construction can help address part of that imbalance by reducing construction timelines and improving manufacturing consistency.

For more information, visit the company’s website at www.Boxabl.com.

NOTE TO INVESTORS: The latest news and updates relating to BXBL are available in the company’s newsroom at https://nnw.fm/BXBL https://ibn.fm/BXBL

Cautionary Note Regarding the Business Combination and Capital Structure. BOXABL Inc. became a publicly traded company through a business combination with FG Merger II Corp., a special purpose acquisition company, completed in July 2026, with the shares beginning trading on the Nasdaq Stock Market under the symbol BXBL on July 20, 2026. Companies that become public through special purpose acquisition transactions may be subject to risks including share price volatility, dilution, limited operating history as a public company, and redemption-related capital reductions. In July 2026 the Company filed a universal mixed shelf registration statement that would permit it to offer up to $500,000,000 of securities over time; any such issuance would be dilutive to existing holders. References to capital raised since inception and to the number of investors are as disclosed by the Company. Readers should review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov, including its periodic reports, in full.

Cautionary Note Regarding Forward-Looking Statements. This publication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including projections of market opportunity and market share, estimates of customer adoption, projections of development and commercialization costs and timelines, expectations regarding the Company’s ability to execute its business model, the deployment of the Casita, the development and potential production of the Baby Box and of stackable and connectable modules, the pursuit of additional state regulatory approvals, expectations concerning relationships with customers, developers, strategic partners, suppliers, governments and regulatory bodies, and the potential for future projects. Such statements are generally identified by words such as “plan”, “project”, “will”, “estimate”, “intend”, “expect”, “believe”, “target”, “continue”, “could”, “may”, “might”, “possible”, “potential” or “predict”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause actual circumstances, events, or results to differ materially, including manufacturing, supply chain, permitting, regulatory, financing, dilution, listing, competitive and market risks, and other risks identified in the Company’s filings with the Securities and Exchange Commission. Do not place undue reliance on such statements. The forward-looking statements in this publication are made as of the date above and IBN undertakes no obligation to update them.

Full Disclaimer. NetworkNewsWire (“NNW”) is a division of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company. IBN has been compensated for advertising and digital media services for BOXABL Inc. This publication is for informational purposes only and is not, and should not be construed as, a research report, investment advice, or a recommendation to buy or sell any security. The information contained herein is believed to be reliable but no guarantee can be made as to its accuracy or completeness. Neither IBN nor NNW is registered as an investme

• VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment modalities.
• Its proprietary BiTAC platform uses two complementary molecules that are designed to activate cytotoxic activity only when both recognize targets on the same tumor cell.
• The company is applying the BiTAC concept to both antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with an emphasis on solid tumors.
• With ADCs and bispecific antibodies attracting substantial investment, VERAXA is operating in oncology markets where technological differentiation can have significant strategic value.

VERAXA Biotech (NASDAQ: VRXA) is developing a new generation of antibody-based cancer therapies at a time when oncology research is increasingly focused on a difficult question: how can powerful treatments be made more selective without sacrificing their ability to kill cancer cells? The wiss biotechnology company is approaching that problem through a portfolio of antibody-drug conjugates (“ADCs”), T-cell engagers (“TCEs”) and engineered antibody formats. At the center of the strategy is its proprietary BiTAC, or Bi-targeted Tumor-Associated Cytotoxicity, concept.

The objective is not simply to produce another antibody with a new target. VERAXA is attempting to change the conditions under which a therapeutic becomes active.

Conventional antibody therapies can recognize a molecular target associated with cancer, but that target may also occur on healthy tissue. ADCs and TCEs can deliver highly potent mechanisms of action, yet their effectiveness can be constrained by toxicity when activity extends beyond the tumor.

VERAXA’s BiTAC architecture is designed around a different principle. Rather than relying on a single molecule carrying two targeting specificities, the approach uses two complementary molecules. The therapeutic effect is intended to become active only when both molecules localize on the same tumor cell. That creates what the company describes as an AND-gated mechanism: target A alone should not be sufficient, and target B alone should not be sufficient. The desired cytotoxic response occurs when both are present together. Improving selectivity can potentially expand the therapeutic index: the separation between a dose that produces an effective response and one that produces unacceptable toxicity.

VERAXA presented initial data from its most advanced BiTAC-TCE program at the 2026 American Association for Cancer Research Annual Meeting in San Diego. The company reported that its candidate attacked cells carrying both targets while sparing cells expressing only one of them. In animal studies, VERAXA reported comparable efficacy to a conventional TCE alongside an improved safety profile.

The findings remain preclinical and will require further validation. But they illustrate the commercial rationale behind the technology: if conditional activation can be translated into human clinical development, it could address one of the persistent challenges associated with highly potent cancer therapeutics.

VERAXA is also applying the concept to ADC development. ADCs combine the targeting capabilities of antibodies with potent cytotoxic payloads, effectively turning the antibody into a delivery mechanism for cancer-killing compounds.

The company has developed additional technologies around this approach, including proprietary biorthogonal click chemistry, site-specific conjugation and hydrophilic payload-linker systems. Its technology suite also includes tumor-selective linkers and a prodrug strategy intended to activate highly potent toxins preferentially in the tumor environment.

These technologies are being developed against a market that has already demonstrated substantial commercial momentum. Grand View Research estimates that the global ADC market was worth about $12.26 billion in 2024 and projects it could reach approximately $32.11 billion by 2033, representing a 10.49% compound annual growth rate from 2025 through 2033 (https://ibn.fm/7X1Wu).

The bispecific antibody market is expanding even more rapidly, according to Precedence Research, which estimates a market of approximately $17.99 billion in 2025 and projects substantial growth through 2035 (https://ibn.fm/qVkNm).

That growth reflects an oncology industry increasingly willing to invest in therapies capable of engaging cancer biology with greater precision. It also creates a competitive environment in which simply entering the ADC or TCE market is not enough. Developers need differentiated biology, credible preclinical evidence and a pathway toward clinical validation.

VERAXA’s pipeline is designed around that requirement. Its most advanced program, VX-A901, is a clinical-stage monoclonal antibody targeting FLT3 for acute myeloid leukemia (“AML”). The therapy is designed to enhance antibody-dependent cellular cytotoxicity and has demonstrated safety and tolerability in Phase I testing, with signs of monotherapy activity reported in heavily pretreated patients.

VERAXA has decided to pursue an out-licensing strategy for VX-A901 as its development emphasis increasingly shifts toward AND-gated modalities and solid-tumor applications.

That strategic focus is significant. Solid tumors remain one of the most difficult areas in oncology because therapeutic targets can be heterogeneous and healthy tissues can share molecular characteristics with malignant cells. A platform capable of requiring multiple tumor-associated signals before activating cytotoxicity could therefore have applications across multiple cancer types if its underlying biology is validated clinically.

For more information, visit the company’s website at www.Veraxa.com.

NOTE TO INVESTORS: The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA

• Study estimates about six million small and midsize family-owned businesses will face transitions by 2035.
• Preparation for that transition starts with reliable numbers and informed guidance.
• Through its strategic planning and advisory practice and investment banking platform, Market Street Capital offers key insight, direction.

Family-owned industrial businesses built over decades are approaching a reckoning: Who runs the company next, and whether that transition happens on the owner’s terms or by default. Market Street Capital, a boutique capital markets and financial advisory firm, works with established middle-market businesses navigating exactly this kind of pivotal moment. The company advises founder-led and family-owned companies on succession planning, sell-side M&A and capital structure decisions well before a transaction is ever on the table, drawing on a platform that has advised on more than $3 billion in completed transactions.

The scale of what’s coming is significant. According to the McKinsey Institute for Economic Mobility, about six million small and midsize businesses will face ownership transitions by 2035 as baby boomer owners retire, with more than one million viable candidates for sale representing up to $5 trillion in enterprise value. Many of these businesses are industrial: manufacturers, fabricators and distributors that have operated under one family for a generation or more.

Yet most owners are not ready. Fewer than one-third of small business owners have a documented succession plan, and many have never obtained a professional valuation, even though the business often represents the bulk of their personal wealth. Family transfer itself is also rarer than owners often assume. Data shows only about 30% of family businesses survive into the second generation, and roughly 12% make it to the third.

Against that backdrop, industrial sell-side M&A activity has been active. PwC’s midyear 2026 outlook found that deal values in industrial manufacturing climbed 28% year over year, with strategic acquirers accounting for the largest share of deal volume on record. The same outlook indicates that buyers, whether strategic and financial, remain active in the sector. In Market Street Capital’s experience, owners who prepare in advance tend to be better positioned in a sale process than those that enter one reactively; individual outcomes vary and no transaction outcome can be assured.

Preparation usually starts with the numbers. A quality of earnings report (“QoE”) is a third-party financial analysis that adjusts reported earnings for one-time or unusual items to show a buyer the company’s true, sustainable performance. When an owner commissions this work before going to market, it is known as a sell-side QoE, which can enable an owner to validate the company’s earnings in advance and may support buyer confidence before due diligence begins. Sellers who skip this step often find that a buyer’s own QoE surfaces issues mid-process, which can slow a deal down or chip away at the final price.

Management depth matters just as much as the financials. In many closely held industrial businesses, the owner is deeply embedded in customer relationships, vendor negotiations and daily decisions. Buyers view that concentration as risk: Businesses with stronger management depth and delegated responsibilities are generally viewed as less risky, because buyers want to see continuity beyond the current owner. Building out a second layer of leadership, documenting institutional knowledge, and formalizing customer and vendor relationships all reduce what is often called key person risk, and that reduction shows up directly in valuation and deal terms.

Collectively, generational transfer pressure, an active industrial M&A market and buyer scrutiny of earnings quality and leadership depth mean that sale readiness is no longer something an owner can address in the final months before a transaction. It has to be built over time.

This is where Market Street Capital’s advisory work enters the picture. The company’s strategic planning and advisory practice supports clients through recapitalizations, divestitures, executive leadership transitions, governance initiatives and succession planning. At the same time, its investment banking platform covers sell-side and buy-side mergers and acquisitions, capital structure optimization and valuation services. Market Street Capital focuses on established businesses with enterprise values between $10 million and $1 billion, including founder-led and family-owned companies, which places much of its client base directly inside the segment now facing this generational transition.

For family-owned industrial businesses, the work of getting sale-ready, cleaning up earnings, building management depth and thinking through succession options is not a last-minute exercise. It is a multiyear process, and companies such as Market Street Capital provide advisory support to owners through it well before a transaction is on the table.

For more information about the company, visit www.MarketStreetCP.com.

Disclosures:

This article is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any such offer may be made only pursuant to definitive offering materials and applicable transaction documents.

Nothing in this article is tax, legal or accounting advice. Readers should consult their own advisers.

Market data and third-party information are from sources believed to be reliable but have not been independently verified. No representation is made as to accuracy or completeness. Statements about financing structures and transaction outcomes are general in nature; no financing or transaction outcome can be assured. Any investment in securities is illiquid and speculative and is subject to a risk of loss, including a risk of the total loss of principal. Market Street Capital and its associated persons may have conflicts of interest, including transaction-based compensation, in connection with the services described.

Broker-dealer services are provided by Pickwick Capital Partners, LLC, Member FINRA/SIPC.

• Energy is the foundation of everything the global economy runs on, from manufacturing to transportation to food production.
• The United States has made real progress reducing its reliance on imported ammonia, with net import reliance falling to about 5% in 2025.
• Frontieras North America is supporting that trend toward diversification with a technology it calls Solid Carbon Fractionation, branded FASForm(TM).

American farmers depend on nitrogen fertilizer, and nitrogen fertilizer depends on energy. That bridge is why fertilizer security at its core is actually an energy story … and problem. It is also why Frontieras North America is positioning its coal-based FASForm(TM) technology, along with the designer carbon product the technology yields, FASCarbon(TM), as part of the answer.

From manufacturing to transportation to food production, energy is the foundation of everything the U.S. economy runs on. When domestic energy supply is squeezed, the effects ripple outward fast, and agriculture feels it as directly as any sector. Nitrogen fertilizer is made from ammonia, and ammonia is made by combining hydrogen with nitrogen from the air. That hydrogen almost always comes from natural gas. Natural gas typically accounts for more than 60% of the levelized cost of producing ammonia through the conventional process, so when gas prices move, fertilizer prices move with them.

This year, we saw the effects of that exposure, bringing it from the theoretical to the real world. In spring 2026, conflict in the Middle East disrupted the Strait of Hormuz, a corridor that handles roughly 20% of global natural gas exports and half of global urea and sulfur exports. Anhydrous ammonia prices climbed past $1,126 per ton by mid-May, a jump of more than 25% in a matter of months. Nitrogen fertilizer already represents 33 to 44% of total corn production costs, so a spike of that size lands directly on farm margins and, eventually, on grocery bills.

The United States has made real progress reducing its reliance on imported ammonia, with net import reliance falling to about 5% in 2025, down from 13% just a few years earlier. But domestic production still runs almost entirely on natural gas, which means American fertilizer costs stay tied to a single, globally traded commodity. A supply chain built around one input and one production pathway is a supply chain with one point of failure. Diversifying the energy inputs behind fertilizer production is now a matter of both economic stability and national security, since food production cannot pause while energy markets sort themselves out.

Frontieras North America is building toward that diversification with a technology it calls Solid Carbon Fractionation, branded FASForm(TM). The process runs coal through thermal cracking and distillation, without combustion, to separate it into hydrogen, methane, naphtha, diesel, aviation fuel and FASCarbon, a low-sulfur solid carbon product. A single FASForm facility processes 7,500 tons of coal a day, or roughly 2.7 million tons a year. The closed-loop process also produces more than 20 million standard cubic feet of hydrogen daily, which Frontieras uses to power its facilities, making the company’s first plant potentially the first hydrogen-powered plant in the United States.

Hydrogen is the input ammonia production needs, and FASForm generates it from coal rather than natural gas. Frontieras built the technology because of what coal is worth as a feedstock, not as a response to how conventional coal combustion is viewed. The company holds patents in nine countries, including the U.S. and Canada, covering roughly 85% of the global coal market. Coal still meets nearly 40% of global electricity demand, and Frontieras’ position is straightforward: Coal has never been the problem; underuse of its full value has been.

The environmental results follow from the process rather than driving it. FASCarbon runs at less than 1% sulfur and is free of heavy metals, and the FASForm process produces zero waste. Those outcomes matter, but they are a byproduct of extracting more value from a domestic resource, not the reason the technology exists.

The $850 million Mason County project gives the company a working example of what a coal-based hydrogen platform looks like at industrial scale. It also provides a case study for how domestic feedstock diversity can steady an agricultural input market that has shown, repeatedly, how exposed it still is to energy shocks half a world away. As construction moves forward, the facility will serve as an early test of how coal-derived hydrogen can compete with natural gas as a fertilizer input at commercial scale. When it does, Frontieras will have built more than a single plant — the company will have laid out a domestic alternative for an industry that has few of them.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

• Earth Science Tech held its first annual meeting of stockholders, virtually, on August 31, 2026+
• The shareholders authorized the Board to pursue a reverse stock split, if deemed necessary, to help the company uplist to a national exchange like Nasdaq or NYSE
• During the meeting, stockholders authorized the Board’s Independent Special Committee to negotiate the retirement of the Series B Preferred Stock, which would eliminate the current dual-class voting structure
• The shareholders also ratified the appointment of Semple, Marchal & Cooper LLP, as an independent registered public accounting firm, re-elected seven director nominees, and authorized a new non-dilutive executive compensation framework

Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, recently held its first Annual Meeting of Stockholders. During the meeting, shareholders voted on and approved several proposals on the company’s uplisting strategy: an offer to purchase and retire the Series B Preferred stock, re-election of seven director nominees, appointment of an independent registered public accounting firm, and new executive compensation structure (https://ibn.fm/HIqJ9).

Shareholders approved ETST’s intention to pursue a reverse stock split, valid for a period of 12 months. Per the authorization, the Board will make the decision on the reverse stock split, if it considers it necessary to meet the bid price requirements for an uplisting to Nasdaq or NYSE. Giorgio R. Saumat, CEO and Chairman of the Board, nonetheless emphasized that he will not “advocate or hope for or push for it at the current prices.”

Mr. Saumat also noted that the split would only be necessary if the company uplists to Nasdaq or NYSE, not OTCQB or OTCQX. Still, he mentioned pending SEC rule proposals that would classify the latter two exchanges as national exchanges and which, if passed, would negate the need for a reverse stock split entirely. For current shareholders, this confirms that management views the authorization strictly as a dormant contingency lever, protecting equity holders from unnecessary structural manipulation.

Secondly, ETST’s shareholders authorized the Board’s Independent Special Committee to negotiate the retirement of the Series B Preferred Stock, which would eliminate the current dual-class voting structure. Removing this structure would better align voting power with shareholders’ economic interests and attract institutional investors. However, according to Mr. Saumat, who personally holds these shares, executing this now-authorized proposal would require the company to lay out cash to purchase these shares. His reservations underscore management’s and the company’s public commitment to extreme capital discipline.

For his part, Mr. Saumat views the Series B Preferred Stock as “insurance” given his large common equity position. He expressed skepticism that a special committee could formulate a cash valuation that aligns with his internal pricing. He also stated that management could explore “other possible ways” to achieve this governance milestone without expending the company’s cash resources.

The shareholders also authorized the creation of a new framework, to be reviewed every three years, whereby the company awards non-dilutive, cash-only compensation to executives. This structure will be based exclusively on performance-based cash bonuses instead of stock options and equity grants that otherwise dilute shareholder equity. This new framework underscores the Board’s confidence in the cash-generative capacity of its integrated healthcare operations and firmly aligns executive incentives with bottom-line profitability rather than share issuance. Lastly, shareholders ratified the appointment of Semple, Marchal & Cooper LLP as the accounting firm, and re-elected all seven director nominees to the Board for the upcoming year.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

• Energy security depends on more than pipelines, plants and reserves. It depends on experienced people who know how to run and manage them.
• Frontieras’s Mason County project is expected to create approximately 200 full-time jobs, with wages averaging three times the average income for the area, along with roughly 2,000 construction jobs during the build phase.
• The plant itself will process 7,500 tons of coal per day using FASForm(TM), the company’s Solid Carbon Fractionation process, producing diesel, naphtha, aviation fuel, hydrogen, methane and FASCarbon(TM), a clean-coal product.

A domestic energy project only strengthens the country if it first strengthens the community that builds it. In Point Pleasant, West Virginia, that is the promise behind Frontieras North America and its FASForm coal facility, a project the company says will bring approximately 200 full-time jobs and roughly 2,000 construction positions to Mason County.

Energy security depends on more than pipelines, plants and reserves. It requires people who know how to run and handle them. The United States has spent decades letting its domestic energy workforce shrink, particularly in coal country, and that erosion carries its own risk. A country cannot rebuild energy capacity quickly if it no longer has the trained labor pool to staff it.

Appalachia is a clear example of what that erosion looks like. Coal mining employment across the region fell from nearly 56,000 jobs in 2010 to about 28,000 in 2023, a nearly 50% decline in just over a decade. West Virginia alone employed 14,014 coal workers in 2023, down from tens of thousands a generation earlier. Every mine that closes displaces trained operators, engineers and technicians, and that expertise does not come back overnight once it is gone.

Rebuilding domestic energy capacity means rebuilding the workforce behind it at the same time. New industrial projects that hire and train locally do double duty: They add supply to the energy system, and they rebuild the skilled labor base the system depends on for the long run. Communities that have spent years watching energy jobs disappear are also the communities best positioned to staff the next generation of energy projects, provided the jobs actually show up.

That is the case Frontieras is making in Mason County. The company’s first commercial FASForm facility broke ground in Point Pleasant earlier this year, representing an estimated $850 million investment along the Ohio River. The project is expected to create approximately 200 full-time jobs, with wages averaging three times the average income for the area, along with roughly 2,000 construction jobs during the build phase.

“This groundbreaking marks a decisive step in the commercialization of FASForm(TM) and the return of serious industrial investment to America’s energy regions,” said Frontieras cofounder and CEO Matthew McKean. “We’re building a new class of energy infrastructure that extracts maximum value from domestic resources — profitably, at scale and with a zero-waste design.” For a county with an estimated population of about 24,700 people, a project of that size carries real weight.

Frontieras hired West Virginia native Robert Portz as vice president of operations and engineering to lead the plant through construction and startup. His role includes coordination with engineering firms, construction oversight, workforce development, and commissioning of the plant. Portz previously helped build one of the most profitable renewable diesel operations in Wyoming, and Frontieras selected him in part because of his refinery background and his ties to the state.

The plant itself will process 7,500 tons of coal per day using FASForm, the company’s Solid Carbon Fractionation process, producing diesel, naphtha, aviation fuel, hydrogen, methane and FASCarbon(TM), a clean-coal product. Frontieras did not choose Mason County randomly. The company has cited the county’s access to coal, skilled labor, and rail and water transportation as reasons it beat out competing sites in Texas and Wyoming.

State officials have framed the project as validation of the region’s labor pool. West Virginia Senator Eric Tarr described the current wave of investment in his district, which includes Frontieras alongside the nearby Nucor steel plant, as “a gold rush” for the area. Point Pleasant Mayor Amber Tatterson has said the city is now working to upgrade local infrastructure and utilities to keep pace with the growth.

For Mason County, the FASForm plant is a bet that a coal-fired workforce, given the right technology and the right jobs, still has plenty left to build. If the plant hires and trains at the scale Frontieras and county leaders expect, Point Pleasant will have more than a new employer on the Ohio River. It will have a template for how a coal community rebuilds its labor base around a new generation of coal technology, rather than watching that expertise leave for good.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras